Higher PLR and PHR Linked to Worse Systemic Sclerosis Activity
A case of systemic sclerosis. Source: Nevit Dilmen / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

Higher PLR and PHR Linked to Worse Systemic Sclerosis Activity

  Although the medical field has made significant strides over the years, there is still a lot we don’t know about the body. For example, what can we learn about…

Continue Reading Higher PLR and PHR Linked to Worse Systemic Sclerosis Activity
Belimumab Granted Orphan Drug Designation for Systemic Sclerosis
A case of systemic sclerosis. Source: Nevit Dilmen / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

Belimumab Granted Orphan Drug Designation for Systemic Sclerosis

Initially, belimumab (sold under the brand name BENLYSTA) was approved for the treatment of patients for lupus and lupus nephritis. It was the first FDA-approved biologic treatment within this indication.…

Continue Reading Belimumab Granted Orphan Drug Designation for Systemic Sclerosis

Positive Phase 1 Trial Results for Systemic Sclerosis-Associated Interstitial Lung Disease Treatment

Prometheus Biosciences Inc. has just announced positive results from their Phase 1 investigation for a new treatment for systemic sclerosis-associated interstitial lung disease (SSC-ILD). This trial investigated PRA023, an anti-TL1A…

Continue Reading Positive Phase 1 Trial Results for Systemic Sclerosis-Associated Interstitial Lung Disease Treatment
June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

June is Scleroderma Awareness Month: Spreading Rare Disease Awareness

According to a story from Scleroderma News, June is recognized as Scleroderma Awareness Month. While physical distancing as a result of the ongoing coronavirus/COVID-19 pandemic may keep some folks at…

Continue Reading June is Scleroderma Awareness Month: Spreading Rare Disease Awareness
Scleroderma Symptoms Shown to Be Alleviated with Tracleer Treatment
source: pixabay.com

Scleroderma Symptoms Shown to Be Alleviated with Tracleer Treatment

by Danielle Bradshaw from In The Cloud Copy A year-long study has shown that Tracleer greatly reduces the skin-related symptoms of scleroderma. The results also showed that although it helped…

Continue Reading Scleroderma Symptoms Shown to Be Alleviated with Tracleer Treatment
Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis
Pexels / Pixabay

Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis

  A news release from Benzinga shares that biotechnology company Emerald Health Pharmaceuticals is beginning a Phase 2 clinical study on EHP-101 as a treatment for patients with systemic sclerosis.…

Continue Reading Emerald Health Pharmaceuticals Initiates Phase 2 Clinical Study on Systemic Sclerosis
Two Part Treatment Proven Superior for Pulmonary Arterial Hypertension
source: pixabay.com

Two Part Treatment Proven Superior for Pulmonary Arterial Hypertension

According to a story from Pulmonary Hypertension News, the results of a recent phase 3 clinical trial have determined that patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) stand…

Continue Reading Two Part Treatment Proven Superior for Pulmonary Arterial Hypertension
ICYMI: Privigen Granted Orphan Drug Designation For Treatment of Systemic Scleroderma
source: pixabay.com

ICYMI: Privigen Granted Orphan Drug Designation For Treatment of Systemic Scleroderma

CSL Behring has recently received the Orphan Drug designation for Privigen for the treatment of systemic scleroderma. Privigen has also been granted the Fast Track designation. This therapy has been…

Continue Reading ICYMI: Privigen Granted Orphan Drug Designation For Treatment of Systemic Scleroderma